84 related articles for article (PubMed ID: 1317284)
1. [Observation on the changes in the frequency of end-plate potentials evoked by sera with different antibodies from patients with myasthenia gravis in nerve-muscle preparation of rats].
Lu C
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Feb; 25(1):44-6, 63. PubMed ID: 1317284
[TBL] [Abstract][Full Text] [Related]
2. Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects.
Burres SA; Crayton JW; Gomez CM; Richman DP
Ann Neurol; 1981 Jun; 9(6):563-8. PubMed ID: 6167199
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiological effects of myasthenic serum factors studied in mouse muscle.
Lerrick AJ; Wray D; Vincent A; Newsom-Davis J
Ann Neurol; 1983 Feb; 13(2):186-91. PubMed ID: 6830177
[TBL] [Abstract][Full Text] [Related]
4. End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis.
Ruff RL; Lennon VA
Ann Neurol; 1998 Mar; 43(3):370-9. PubMed ID: 9506554
[TBL] [Abstract][Full Text] [Related]
5. Tools to differentiate immunologic and non-immunologic myasthenia gravis in infancy.
Garcia Erro MI; Sica RE; Losavio AS; Muchnik S; Arroyo H
Neuropediatrics; 1988 May; 19(2):92-5. PubMed ID: 3374767
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholine receptor antibody characteristics in myasthenia gravis. III. Patients with low anti-AChR antibody levels.
Vincent A; Newsom-Davis J
Clin Exp Immunol; 1985 Jun; 60(3):631-6. PubMed ID: 2410169
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
[TBL] [Abstract][Full Text] [Related]
8. [Study of antibodies to motor end-plate in ocular myasthenia gravis].
Kinoshita I; Tsujihata M; Motomura M; Yoshimura T; Nagataki S
Rinsho Shinkeigaku; 1991 May; 31(5):500-4. PubMed ID: 1934762
[TBL] [Abstract][Full Text] [Related]
9. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
[TBL] [Abstract][Full Text] [Related]
10. Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases.
Vincent A; Cull-Candy SG; Newsom-Davis J; Trautmann A; Molenaar PC; Polak RL
Muscle Nerve; 1981; 4(4):306-18. PubMed ID: 7254233
[TBL] [Abstract][Full Text] [Related]
11. Absence of anti-acetylcholine receptor antibodies in Praomys (Mastomys) natalensis.
Vincent A; Solleveld HA
Clin Exp Immunol; 1981 Jan; 43(1):94-8. PubMed ID: 7249398
[TBL] [Abstract][Full Text] [Related]
12. Structure-function correlations in myasthenia gravis and a new myasthenic syndrome.
Engel AG; Lambert EH
Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):469-77. PubMed ID: 220007
[TBL] [Abstract][Full Text] [Related]
13. Anti-AChR-negative myasthenia gravis: clinical and immunological features.
Evoli A; Bartoccioni E; Batocchi AP; Scuderi F; Tonali P
Clin Invest Med; 1989 Apr; 12(2):104-9. PubMed ID: 2706833
[TBL] [Abstract][Full Text] [Related]
14. Antigenic modulation of human myotube acetylcholine receptor by myasthenic sera. Serum titer determines receptor internalization rate.
Tzartos SJ; Sophianos D; Zimmerman K; Starzinski-Powitz A
J Immunol; 1986 May; 136(9):3231-8. PubMed ID: 3958494
[TBL] [Abstract][Full Text] [Related]
15. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro.
Burges J; Wray DW; Pizzighella S; Hall Z; Vincent A
Muscle Nerve; 1990 May; 13(5):407-13. PubMed ID: 2345558
[TBL] [Abstract][Full Text] [Related]
16. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
17. Resistance to experimental autoimmune myasthenia gravis in genetically inbred rats. Association with decreased amounts of in situ acetylcholine receptor-antibody complexes.
Biesecker G; Koffler D
J Immunol; 1988 May; 140(10):3406-10. PubMed ID: 3258882
[TBL] [Abstract][Full Text] [Related]
18. Experimental autoimmune myasthenia gravis: the rabbit as an animal model.
Eldefrawi ME
Fed Proc; 1978 Dec; 37(14):2823-7. PubMed ID: 720635
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
Vincent A; Newsom-Davis J
Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
[TBL] [Abstract][Full Text] [Related]
20. Frequency of seronegativity in adult-acquired generalized myasthenia gravis.
Chan KH; Lachance DH; Harper CM; Lennon VA
Muscle Nerve; 2007 Nov; 36(5):651-8. PubMed ID: 17654558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
